SciSparc-Clearmind Collaboration Leads to Publication of Patent for Binge Behaviour ...
The patent refers to SciSparc’s innovative combination therapy of N-Acylethanolamines and Clearmind’s MEAI, (5-methoxy-2-aminoindane) addressing binge behaviour, including alcohol consumption, eating, ...
Clearmind announces publication of patent for binge behavior treatment
Clearmind Medicine (CMND) announced a patent publication by the Instituto Mexicano de la Propriedad Industrial, the National Mexico Patent ...
Clearmind Medicine Announces Publication of Patent for Binge Behavior Psychedelic ...
Vancouver, Canada, Feb. 04, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel ...
Ever-Growing USA on MSN9 天
Arialief Reviews 2025 (Consumer Report Analysis) Is This Supplement Good For Sciatic Nerve ...
Arialief is a comprehensive nerve health supplement that specifically targets sciatic nerve pain and claims to provide ...